397 related articles for article (PubMed ID: 26120584)
1. The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.
Chambel SS; Santos-Gonçalves A; Duarte TL
Biomed Res Int; 2015; 2015():597134. PubMed ID: 26120584
[TBL] [Abstract][Full Text] [Related]
2. Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.
Li J; Sapper TN; Mah E; Rudraiah S; Schill KE; Chitchumroonchokchai C; Moller MV; McDonald JD; Rohrer PR; Manautou JE; Bruno RS
Mol Nutr Food Res; 2016 Apr; 60(4):858-70. PubMed ID: 26679056
[TBL] [Abstract][Full Text] [Related]
3. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.
Huang B; Xiong X; Zhang L; Liu X; Wang Y; Gong X; Sang Q; Lu Y; Qu H; Zheng H; Zheng Y
J Mol Cell Biol; 2021 Oct; 13(7):527-539. PubMed ID: 34048566
[TBL] [Abstract][Full Text] [Related]
4. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor.
Ka SO; Bang IH; Bae EJ; Park BH
FASEB J; 2017 Sep; 31(9):3999-4010. PubMed ID: 28536120
[TBL] [Abstract][Full Text] [Related]
7. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.
Wang C; Cui Y; Li C; Zhang Y; Xu S; Li X; Li H; Zhang X
Lipids Health Dis; 2013 Nov; 12():165. PubMed ID: 24188280
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.
Ramadori P; Drescher H; Erschfeld S; Schumacher F; Berger C; Fragoulis A; Schenkel J; Kensler TW; Wruck CJ; Trautwein C; Kroy DC; Streetz KL
Free Radic Biol Med; 2016 Feb; 91():114-26. PubMed ID: 26698665
[TBL] [Abstract][Full Text] [Related]
10. [Effect of total flavones of hawthorn leafonon expression of COX-2/Nrf2 in liver of rats with nonalcoholic steatohepatitis].
Li XD; Chen ZY; Yu JS; Wang DJ; Yan MX
Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):711-715. PubMed ID: 28871698
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway.
Teimouri M; Hosseini H; Shabani M; Koushki M; Noorbakhsh F; Meshkani R
IUBMB Life; 2020 Mar; 72(3):361-372. PubMed ID: 31889412
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Manne V; Handa P; Kowdley KV
Clin Liver Dis; 2018 Feb; 22(1):23-37. PubMed ID: 29128059
[TBL] [Abstract][Full Text] [Related]
13. Effect of Total Flavone of Haw Leaves on Nuclear Factor Erythroid-2 Related Factor and Other Related Factors in Nonalcoholic Steatohepatitis Rats.
Wang DJ; Cai YQ; Pan SZ; Zhang LZ; Chen YX; Chen FM; Jin M; Yan MX; Li XD; Chen ZY
Chin J Integr Med; 2018 Apr; 24(4):265-271. PubMed ID: 26919834
[TBL] [Abstract][Full Text] [Related]
14. Does hepatic oxidative stress enhance activation of nuclear factor-E2-related factor in patients with nonalcoholic steatohepatitis?
Takahashi Y; Kobayashi Y; Kawata K; Kawamura K; Sumiyoshi S; Noritake H; Watanabe S; Chida T; Souda K; Sakaguchi T; Nakamura H; Suda T
Antioxid Redox Signal; 2014 Jan; 20(3):538-43. PubMed ID: 23822105
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease.
Liu W; Baker SS; Baker RD; Zhu L
Curr Drug Targets; 2015; 16(12):1301-14. PubMed ID: 25915484
[TBL] [Abstract][Full Text] [Related]
16. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet.
Liu Z; Dou W; Ni Z; Wen Q; Zhang R; Qin M; Wang X; Tang H; Cao Y; Wang J; Zhao S
Mol Med Rep; 2016 Aug; 14(2):1323-31. PubMed ID: 27315552
[TBL] [Abstract][Full Text] [Related]
17. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.
Chen G; Ni Y; Nagata N; Xu L; Ota T
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563875
[TBL] [Abstract][Full Text] [Related]
18. Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes.
Pilar Valdecantos M; Prieto-Hontoria PL; Pardo V; Módol T; Santamaría B; Weber M; Herrero L; Serra D; Muntané J; Cuadrado A; Moreno-Aliaga MJ; Alfredo Martínez J; Valverde ÁM
Free Radic Biol Med; 2015 Jul; 84():263-278. PubMed ID: 25841776
[TBL] [Abstract][Full Text] [Related]
19. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity.
Chen X; Xue H; Fang W; Chen K; Chen S; Yang W; Shen T; Chen X; Zhang P; Ling W
Redox Biol; 2019 Feb; 21():101068. PubMed ID: 30684890
[TBL] [Abstract][Full Text] [Related]
20. p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease.
Yan Z; Miao X; Zhang B; Xie J
Life Sci; 2018 Dec; 215():64-72. PubMed ID: 30473026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
